CN103055295B - Chinese medicine for treating lumbar disc herniation and hyperosteogeny and use method of Chinese medicine - Google Patents
Chinese medicine for treating lumbar disc herniation and hyperosteogeny and use method of Chinese medicine Download PDFInfo
- Publication number
- CN103055295B CN103055295B CN201310008908.2A CN201310008908A CN103055295B CN 103055295 B CN103055295 B CN 103055295B CN 201310008908 A CN201310008908 A CN 201310008908A CN 103055295 B CN103055295 B CN 103055295B
- Authority
- CN
- China
- Prior art keywords
- grams
- parts
- radix
- rhizoma
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 116
- 238000000034 method Methods 0.000 title claims abstract description 31
- 206010005963 Bone formation increased Diseases 0.000 title claims abstract description 29
- 206010050296 Intervertebral disc protrusion Diseases 0.000 title abstract 5
- 239000002994 raw material Substances 0.000 claims abstract description 29
- 229940079593 drug Drugs 0.000 claims abstract description 24
- 241001180876 Saposhnikovia Species 0.000 claims abstract description 15
- 239000011505 plaster Substances 0.000 claims description 54
- 239000000463 material Substances 0.000 claims description 36
- 208000012287 Prolapse Diseases 0.000 claims description 24
- 239000000758 substrate Substances 0.000 claims description 23
- 241000628997 Flos Species 0.000 claims description 20
- 238000010438 heat treatment Methods 0.000 claims description 19
- 210000000582 semen Anatomy 0.000 claims description 19
- 241000756943 Codonopsis Species 0.000 claims description 18
- 230000032683 aging Effects 0.000 claims description 16
- 239000000843 powder Substances 0.000 claims description 16
- 241001446509 Psoralea Species 0.000 claims description 14
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 claims description 9
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 9
- 239000008158 vegetable oil Substances 0.000 claims description 9
- 238000002791 soaking Methods 0.000 claims description 8
- 238000001816 cooling Methods 0.000 claims description 7
- 238000010298 pulverizing process Methods 0.000 claims description 7
- 230000007480 spreading Effects 0.000 claims description 7
- 238000003892 spreading Methods 0.000 claims description 7
- 238000009835 boiling Methods 0.000 claims description 5
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims description 4
- 108090001030 Lipoproteins Proteins 0.000 claims description 4
- 102000004895 Lipoproteins Human genes 0.000 claims description 4
- 235000010489 acacia gum Nutrition 0.000 claims description 4
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 4
- 239000007766 cera flava Substances 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 238000007873 sieving Methods 0.000 claims description 2
- 238000011282 treatment Methods 0.000 abstract description 38
- 230000000694 effects Effects 0.000 abstract description 31
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 28
- 201000010099 disease Diseases 0.000 abstract description 27
- 208000002193 Pain Diseases 0.000 abstract description 26
- 230000036407 pain Effects 0.000 abstract description 25
- 238000002560 therapeutic procedure Methods 0.000 abstract description 8
- 210000005036 nerve Anatomy 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 4
- 238000011161 development Methods 0.000 abstract description 4
- 238000011084 recovery Methods 0.000 abstract description 3
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 abstract 1
- 241000893536 Epimedium Species 0.000 abstract 1
- 241000208689 Eucommia ulmoides Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 241000331449 Vincetoxicum pycnostelma Species 0.000 abstract 1
- 230000003292 diminished effect Effects 0.000 abstract 1
- 235000018905 epimedium Nutrition 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 235000019991 rice wine Nutrition 0.000 abstract 1
- 238000001356 surgical procedure Methods 0.000 abstract 1
- 230000006870 function Effects 0.000 description 22
- 239000000203 mixture Substances 0.000 description 21
- 239000000126 substance Substances 0.000 description 18
- 230000017531 blood circulation Effects 0.000 description 16
- 210000000988 bone and bone Anatomy 0.000 description 15
- 239000008280 blood Substances 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 13
- 210000003205 muscle Anatomy 0.000 description 12
- 239000007788 liquid Substances 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 9
- 208000025747 Rheumatic disease Diseases 0.000 description 8
- 230000003110 anti-inflammatory effect Effects 0.000 description 8
- 210000004204 blood vessel Anatomy 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 8
- 230000000552 rheumatic effect Effects 0.000 description 8
- 208000006820 Arthralgia Diseases 0.000 description 7
- 210000004351 coronary vessel Anatomy 0.000 description 7
- 210000001624 hip Anatomy 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 150000002596 lactones Chemical class 0.000 description 6
- 231100000915 pathological change Toxicity 0.000 description 6
- 230000036285 pathological change Effects 0.000 description 6
- 238000000554 physical therapy Methods 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- 238000005728 strengthening Methods 0.000 description 6
- 238000000015 thermotherapy Methods 0.000 description 6
- 206010010904 Convulsion Diseases 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 210000003743 erythrocyte Anatomy 0.000 description 5
- 230000005284 excitation Effects 0.000 description 5
- 229930182470 glycoside Natural products 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 201000001881 impotence Diseases 0.000 description 5
- -1 methyl visamminol glycosides Chemical class 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 210000004291 uterus Anatomy 0.000 description 5
- 206010021118 Hypotonia Diseases 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 230000036461 convulsion Effects 0.000 description 4
- 208000017561 flaccidity Diseases 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 230000002107 myocardial effect Effects 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 210000004872 soft tissue Anatomy 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 238000001467 acupuncture Methods 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 230000036592 analgesia Effects 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 150000002338 glycosides Chemical class 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000002414 leg Anatomy 0.000 description 3
- 230000001537 neural effect Effects 0.000 description 3
- 230000008520 organization Effects 0.000 description 3
- 210000003024 peritoneal macrophage Anatomy 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 210000003497 sciatic nerve Anatomy 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 2
- SYTGUXGLBXTALU-UHFFFAOYSA-N 2h-1,4-oxazine-3-carboxylic acid Chemical compound OC(=O)C1=NC=COC1 SYTGUXGLBXTALU-UHFFFAOYSA-N 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 208000010228 Erectile Dysfunction Diseases 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010020880 Hypertrophy Diseases 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 206010039897 Sedation Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- OFECPTGTEKSUPH-UHFFFAOYSA-N Visamminol Natural products CC1=CC(=O)c2cc3CC(Oc3cc2O1)C(C)(C)O OFECPTGTEKSUPH-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 235000001785 ferulic acid Nutrition 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 2
- 229940114124 ferulic acid Drugs 0.000 description 2
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 230000002650 habitual effect Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000013521 mastic Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 239000003973 paint Substances 0.000 description 2
- YQBNJPACAUPNLV-UHFFFAOYSA-N peucedanin Chemical compound O1C(=O)C=CC2=C1C=C1OC(C(C)C)=C(OC)C1=C2 YQBNJPACAUPNLV-UHFFFAOYSA-N 0.000 description 2
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 108010048734 sclerotin Proteins 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 239000002912 waste gas Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- VXNZUUAINFGPBY-UHFFFAOYSA-N 1-Butene Chemical compound CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010061623 Adverse drug reaction Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- ATDBDSBKYKMRGZ-ZDUSSCGKSA-N Cimifugin Chemical compound O1C(CO)=CC(=O)C2=C1C=C1O[C@H](C(C)(C)O)CC1=C2OC ATDBDSBKYKMRGZ-ZDUSSCGKSA-N 0.000 description 1
- ATDBDSBKYKMRGZ-UHFFFAOYSA-N Cimifugin Natural products O1C(CO)=CC(=O)C2=C1C=C1OC(C(C)(C)O)CC1=C2OC ATDBDSBKYKMRGZ-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 241001362421 Epimedium brevicornu Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000002513 Flank pain Diseases 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- TZJALUIVHRYQQB-XFDQAQKOSA-N Icariin Natural products O(C)c1ccc(C2=C(O[C@H]3[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)C(=O)c3c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O4)c(C/C=C(\C)/C)c3O2)cc1 TZJALUIVHRYQQB-XFDQAQKOSA-N 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010022678 Intestinal infections Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028391 Musculoskeletal Pain Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 208000031845 Pernicious anaemia Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- LHNKBXRFNPMIBR-UHFFFAOYSA-N Picrotoxin Natural products CC(C)(O)C1(O)C2OC(=O)C1C3(O)C4OC4C5C(=O)OC2C35C LHNKBXRFNPMIBR-UHFFFAOYSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- 241000607760 Shigella sonnei Species 0.000 description 1
- 208000007613 Shoulder Pain Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 241000934136 Verruca Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- ORXKASWXOVPKDV-UBWBUNFISA-N Yuccagenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)C[C@@H](O)[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 ORXKASWXOVPKDV-UBWBUNFISA-N 0.000 description 1
- JLISZLJGTVNTPC-UBWBUNFISA-N Yuccagenin Natural products C[C@@H]1CC[C@@]2(OC1)O[C@H]3C[C@H]4[C@@H]5CCC6=C[C@@H](O)[C@H](O)C[C@]6(C)[C@H]5CC[C@]4(C)[C@H]3[C@@H]2C JLISZLJGTVNTPC-UBWBUNFISA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000001004 anti-acetylcholinic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- COUXBBBIXWWAEP-AGUBZPQCSA-N asperuloside Natural products CC(=O)OCC1=C[C@@H]2OC(=O)C3=CO[C@@H](OC[C@H]4O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]4O)[C@H]1[C@H]23 COUXBBBIXWWAEP-AGUBZPQCSA-N 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 230000010478 bone regeneration Effects 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000001595 contractor effect Effects 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- OAUREGNZECGNQS-UHFFFAOYSA-N corylifolin Natural products O1C=2C=C(O)C(CC=C(C)C)=CC=2C(=O)CC1C1=CC=C(O)C=C1 OAUREGNZECGNQS-UHFFFAOYSA-N 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- WUOIMLIHAHOCCR-UHFFFAOYSA-N curculigoside Natural products COc1ccc(OC2OC(CO)C(O)C(O)C2O)c(OC)c1C(=O)OCc3cc(O)ccc3OC4OC(CO)C(O)C(O)C4O WUOIMLIHAHOCCR-UHFFFAOYSA-N 0.000 description 1
- SJJRKHVKAXVFJQ-UHFFFAOYSA-N curculigoside I Natural products COC1=CC=CC(OC)=C1C(=O)OCC1=CC(O)=CC=C1OC1C(O)C(O)C(O)C(CO)O1 SJJRKHVKAXVFJQ-UHFFFAOYSA-N 0.000 description 1
- SJJRKHVKAXVFJQ-QKYBYQKWSA-N curculigoside a Chemical compound COC1=CC=CC(OC)=C1C(=O)OCC1=CC(O)=CC=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 SJJRKHVKAXVFJQ-QKYBYQKWSA-N 0.000 description 1
- 229930195443 cynapanoside Natural products 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 108091005899 fibrous proteins Proteins 0.000 description 1
- 102000034240 fibrous proteins Human genes 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- XGVJWXAYKUHDOO-UHFFFAOYSA-N galanthidine Natural products C1CN2CC3=CC=4OCOC=4C=C3C3C2C1=CC(O)C3O XGVJWXAYKUHDOO-UHFFFAOYSA-N 0.000 description 1
- WWULHQLTPGKDAM-UHFFFAOYSA-N gamma-eudesmol Natural products CC(C)C1CC(O)C2(C)CCCC(=C2C1)C WWULHQLTPGKDAM-UHFFFAOYSA-N 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- VOTLUFSYIRHICX-UHFFFAOYSA-N hamaudol Natural products C1C(O)C(C)(C)OC2=C1C(O)=C1C(=O)C=C(C)OC1=C2 VOTLUFSYIRHICX-UHFFFAOYSA-N 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- TZJALUIVHRYQQB-XLRXWWTNSA-N icariin Chemical compound C1=CC(OC)=CC=C1C1=C(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)C(=O)C2=C(O)C=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-XLRXWWTNSA-N 0.000 description 1
- TZJALUIVHRYQQB-UHFFFAOYSA-N icariine Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(C)O2)O)C(=O)C2=C(O)C=C(OC3C(C(O)C(O)C(CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-UHFFFAOYSA-N 0.000 description 1
- 210000003405 ileum Anatomy 0.000 description 1
- 230000007233 immunological mechanism Effects 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- XGVJWXAYKUHDOO-DANNLKNASA-N lycorine Chemical compound C1CN2CC3=CC=4OCOC=4C=C3[C@H]3[C@H]2C1=C[C@H](O)[C@H]3O XGVJWXAYKUHDOO-DANNLKNASA-N 0.000 description 1
- KQAOMBGKIWRWNA-UHFFFAOYSA-N lycorine Natural products OC1C=C2CCN3C2C(C1O)c4cc5OCOc5cc34 KQAOMBGKIWRWNA-UHFFFAOYSA-N 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000009854 mucosal lesion Effects 0.000 description 1
- 210000003887 myelocyte Anatomy 0.000 description 1
- 210000000066 myeloid cell Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000010827 pathological analysis Methods 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 239000005426 pharmaceutical component Substances 0.000 description 1
- 229930015704 phenylpropanoid Natural products 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- 230000007105 physical stamina Effects 0.000 description 1
- VJKUPQSHOVKBCO-AHMKVGDJSA-N picrotoxin Chemical compound O=C([C@@]12O[C@@H]1C[C@]1(O)[C@@]32C)O[C@@H]3[C@H]2[C@@H](C(=C)C)[C@@H]1C(=O)O2.O=C([C@@]12O[C@@H]1C[C@]1(O)[C@@]32C)O[C@@H]3[C@H]2[C@@H](C(C)(O)C)[C@@H]1C(=O)O2 VJKUPQSHOVKBCO-AHMKVGDJSA-N 0.000 description 1
- 210000001369 pituitary-adrenal system Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000001855 preneoplastic effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000002423 protozoacide Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000001846 repelling effect Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- QJVXKWHHAMZTBY-GCPOEHJPSA-N syringin Chemical compound COC1=CC(\C=C\CO)=CC(OC)=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 QJVXKWHHAMZTBY-GCPOEHJPSA-N 0.000 description 1
- QJVXKWHHAMZTBY-KSXIZUIISA-N syringin Natural products COc1cc(C=CCO)cc(OC)c1O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O QJVXKWHHAMZTBY-KSXIZUIISA-N 0.000 description 1
- 229930183580 tangshenoside Natural products 0.000 description 1
- GGGUGZHBAOMSFJ-GADYQYKKSA-N taraxerol Chemical compound CC([C@@H]1CC2)(C)[C@@H](O)CC[C@]1(C)[C@@H]1[C@]2(C)C2=CC[C@@]3(C)CCC(C)(C)C[C@H]3[C@]2(C)CC1 GGGUGZHBAOMSFJ-GADYQYKKSA-N 0.000 description 1
- HYTFUKZLSYXRDX-UHFFFAOYSA-N taraxerol Natural products CC1CCCC2C3(C)CCC4(C)C5CC(C)(C)CCC5(C)C=CC4(C)C3C(O)CC12C HYTFUKZLSYXRDX-UHFFFAOYSA-N 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- DSNBHJFQCNUKMA-SCKDECHMSA-N thromboxane A2 Chemical compound OC(=O)CCC\C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)O[C@@H]2O[C@H]1C2 DSNBHJFQCNUKMA-SCKDECHMSA-N 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 208000029761 vertebral disease Diseases 0.000 description 1
Abstract
The invention relates to a Chinese medicine, and in particular relates to a Chinese medicine for treating lumbar disc herniation and hyperosteogeny and a use method of the Chinese medicine. The Chinese medicine is composed of rhizoma zingiberis, rhizoma typhonii, job's tears, codonopsis pilosula, radix aucklandiae, lovage, divaricate saposhnikovia root, cynanchum paniculatum, eucommia ulmoides oliv, radix morindae officinalis, fructus psoraleae, safflower, angelica, rhizoma curculiginis and epimedium herb. The raw materials are immersed with rice wine for 10-20 days. The Chinese medicine for treating lumbar disc herniation and hyperosteogeny disclosed by the invention has the advantages that treatment effect is quick, treatment and use are convenient, the Chinese medicine is safe in treatment duration, a patient does not need to hardly take medicine, and the Chinese medicine can be prevented from being rejected by other medicines during treatment. By treating lumbar disc herniation and hyperosteogeny with the medicine and corresponding usage, the curing time is shorted by half than that of internal treatment and good effect is immediately taken when attacking. The disease development of the patients who need surgeries because of lumbar disc herniation is greatly slowed by using the therapy for 3-5 days, the pain is practically disappeared for 10 days, the pain condition of nerve drawing of the patients is diminished for 20 days, and the patients are basically recovered for 30 days. Thus, the recovery rate reaches more than 95%.
Description
Technical field
The present invention relates to a kind of Chinese medicine and using method thereof, relate in particular to a kind of Chinese medicine and its using method for the treatment of prolapse of lumbar intervertebral disc and hyperosteogeny.
Background technology
Chinese medicine for oral administration is the main method that the traditional Chinese medical science is cured the disease, when muscles and bones pathological changes that rheumatic ostalgia, outer wound and the degeneration that the traditional Chinese medical science declines in treatment internal function causes, the Chinese medicine that adopts takes agent more, oral medicine method is easy, and medicine absorbs menses blood circulation through digestive system makes human body recovery by drug effect in focus.But there is following shortcoming in oral medicine: 1) drug absorption loss is large; 2) drug side effect easily injures internal organs; 3) arduous to the taste stimulation of sufferer.The sufferer of particularly growing for treatment time, adopts method for oral administration inadvisable.The traditional Chinese medical science has formed external treatment of tcm in development, and external therapy of Chinese herb can be evaded the shortcoming that oral medicine brings, and the world of medicine of China has developed countless external treatment medicine for a long time, for China working people's health has been made huge contribution.External treatment of tcm has advantages of unique, but also has the following disadvantages: 1) drug absorption slowly and drug osmotic deficiency; 2) in the time increasing drug absorption auxiliary agent, easily cause skin aging damaged tissue.
Treatment disease the most important thing is effectively rapid healing, but the different times of human development often can produce some New Type of Diseases, and traditional conventional therapy is fallen short of success for lack of final effort, and hyperosteogeny and prolapse of lumbar intervertebral disc are exactly problems.The current prolapse of lumbar intervertebral disc of World Health Organization's judgement can't effectively be cured in western medicine, can only be by excision and reparation, and the expense that has a big risk is high and effect is undesirable.
Prolapse of lumbar intervertebral disc and lumbar vertebra hyperosteogeny are commonly called as lumbago diseases, and the ailing symptom that two diseases form is substantially similar, and main manifestations is: 1) flank pain, 2) large leg outer side sciatic nerve compressing pain, 3) waist leg movements is restricted.The traditional Chinese medical science is early stage is only commonly referred to as lumbus and leg paralyses pain two kinds of diseases.Along with the continuous progress of modern science technology, emerging in large numbers of the advanced inspection technology such as X-ray, CT, magnetic resonance, relative simple with the diagnosis of lumbar vertebra hyperosteogeny for prolapse of lumbar intervertebral disc.Although diagnosis is simple, World Health Organization (WHO) and western medicine circle all think that prolapse of lumbar intervertebral disc and two kinds of diseases of lumbar vertebra hyperosteogeny cannot effect a radical cure.Though two kinds of diseases can essence be distinguished from check, but Therapeutic Method is basic identical.Western medical treatment adopts antiinflammatory, pain relieving, local nerve sealing or surgical resection, and administering mode is endo-medicine and injection.And Chinese traditional treatment adopts traction, acupuncture, the pipe that puts a chimney on the stove and make the fire draw, massaging to add takes traditional Chinese medicine and external application plaster.Along with electricity is to the quoting of human lives, a series of electric physical therapy product auxiliary treatment such as frequency spectrum, infrared, magnetic shakes, electric shock, acusector, pulse are in recent years in succession developed both at home and abroad.
Some Domestic medicine enterprise has also developed multiple oral medicine and external plaster is exclusively used in this two classes disease, but most of product does not reach radical cure effect for this two classes disease, there is minority product can play temporary transient curative effect to this two classes disease, but can not effectively solve the misery of vast sufferer.Applicant tests and traditional Chinese medical science history is stayed the analysis of plucking case by treatment for many years, according to tcm theory, this two classes disease is carried out to pathology deduction, find that current Chinese and western medicine and various treatment newly developed and method of rehabilitation cannot effect a radical cure the reason of two kinds of diseases, main being just lacks understanding and pathological diagnosis fully to the formation of two kinds of diseases and generation, the disease that combined cause complexity is caused, simple naturopathy or the general anti-inflammatory analgetic of adopting solves, can not effect a radical cure, need to separately seek method.
Summary of the invention
For above deficiency, the invention provides a kind of method that can effectively treat the Chinese medicine of prolapse of lumbar intervertebral disc, hyperosteogeny, chronic rheumatoid osteodynia, waist lower limb shoulder pain, strength vertebra disease and use this Chinese medicine performance optimum medicine efficacy.
The present invention achieves the above object by following scheme:
A kind of Chinese medicine for the treatment of prolapse of lumbar intervertebral disc and hyperosteogeny, be made up of Rhizoma Zingiberis, Rhizoma Typhonii, Semen Coicis, Radix Codonopsis, the Radix Aucklandiae, Rhizoma Chuanxiong, Radix Saposhnikoviae, Radix Cynanchi Paniculati, the Cortex Eucommiae, Ba Ji, Fructus Psoraleae, Flos Carthami, Radix Angelicae Sinensis, Rhizoma Curculiginis, Herba Epimedii, above-mentioned raw materials is made liquid medicine after adding soaking in Chinese liquor 10-20 days.
Preferably, above-mentioned Chinese medicine is made up of the raw material of following weight portion: 8 parts of Rhizoma Zingiberiss, 6 parts of Rhizoma Typhoniis, 15 parts of Semen Coiciss, 10 parts of Radix Codonopsis, 6 parts of the Radix Aucklandiae, 8 parts of Rhizoma Chuanxiong, 8 parts of Radix Saposhnikoviaes, 8 parts of Radix Cynanchi Paniculatis, 10 parts of the Cortexs Eucommiae, 8 parts of halberds of bar, 10 parts of Fructus Psoraleaes, 8 parts, Flos Carthami, 10 parts of Radix Angelicae Sinensis, 10 parts of Rhizoma Curculiginises, 10 parts of Herba Epimedii, above-mentioned raw materials added 1200 parts of soaking in Chinese liquor after 15 days.Above-mentioned Chinese medicine is as the criterion with national medicament weight specification grams part, and the making total amount of medicine is carried out multiple product and determines with the every medicine amount of preparation of basic side number.
The using method of the Chinese medicine of this treatment prolapse of lumbar intervertebral disc and hyperosteogeny, is applied to focus outward by above-mentioned herb liquid, then heats physical therapy, for keeping additional temperature to make human body sensory comfortable, prevent the too high body skin of burning of outer temperature, impact treatment, when heating physical therapy, human body heating temperature is no more than 45 degree.
Further, in thermotherapy after 2 hours, in affected area externally applied plaster, this plaster is made up of following raw material again: 8 parts of Rhizoma Zingiberiss, 6 parts of Rhizoma Typhoniis, 15 parts of Semen Coiciss, 10 parts of Radix Codonopsis, 6 parts of the Radix Aucklandiae, 8 parts of Rhizoma Chuanxiong, 8 parts of Radix Saposhnikoviaes, 8 parts of Radix Cynanchi Paniculatis, 10 parts of the Cortexs Eucommiae, 8 parts of halberds of bar, 10 parts of Fructus Psoraleaes, 8 parts, Flos Carthami, 10 parts of Radix Angelicae Sinensis, 10 parts of Rhizoma Curculiginises, 10 parts of Herba Epimedii.
Preferably, the manufacture method of this plaster comprises the material pulverizing of above-mentioned plaster, make nanoscale fine powder drug material after sieving, and plaster substrate and fine powder drug material are formulated as to plaster.Plaster substrate is made up of Vegetable oil lipoprotein, Colophonium, arabic gum, Cera Flava, azone raw material, heat each raw material, boil, spreading for cooling, place that within 3 months, to move back malicious ageing for subsequent use, the substrate after ageing is heated and dissolves and fine powder drug material is added in the gum base dissolving and makes plaster.
Preferably, the weight ratio of above-mentioned plaster substrate raw material is: Vegetable oil lipoprotein: Colophonium: arabic gum: Cera Flava: azone is 1:4:4:1:0.3.
Preferably, each outer being attached between 4 hours to 24 hours of above-mentioned plaster.Plaster outer plaster belongs to nature and absorbs, by body temperature, plaster body is heated, make ingredient from mastic, penetrate into human body, reach the object of inhaling medicine, so the external application time, too short mastic medicine retained waste, plaster is through sticking for a long time human body, and ingredient absorbs and inside and outside aerofluxus, under liquid comprehensive function, changed the interior material composition of plaster, therefore general externally applied plaster does not exceed 24 hours.Prolapse of lumbar intervertebral disc and lumbar vertebra hyperosteogeny belong to chronic disease need, through regular period treatment, therefore require the plaster of exchangining cards containing all personal details and become sworn brothers every day.
The main chemical compositions of Rhizoma Zingiberis is that volatile oil includes zingiberol, can Cell protection, liver, there is the effect of rising blood pressure, and can suppress the convulsions that central nervous excitation produces, there is function of gallbladder promoting, analgesia, antiplatelet and doubt the effects such as poly-, antiinflammatory, antibacterial, protozoacide.Its function comprises: warming spleen and stomach for dispelling cold, recuperating depleted YANG is promoted blood circulation, and can suppress the discomfort that waist lower limb central nervous excitation produces, the neural tenderness that the thrombosis that the doubtful collection of prevention platelet produces produces Vascular diseases.
The main chemical compositions of Rhizoma Typhonii is sitosterol and glucoside, under low calcium state, has obvious cardiotonic, has the effect of anti-anoxemia, calmness, analgesia, antiinflammatory, and analgesic activity is lasting.Its function comprises: can be timid except body internal congestion expectorant thing, and dredge and fall apart except doubting knot, there is pain relieving, force painstaking effort easypro logical, the effect of the unimpeded pain relieving of blood circulation.
The main component of Semen Coicis comprises Semen Coicis fat, fatty oil, and containing myristic acid, Semen Coicis oil low dose has excitation to breathing, and heavy dose has paralysis effect, can make lung blood vessel significantly expand, and has diuresis, antitumor action.Its function comprises: key spleen Three is wet, eliminating impediment antidiarrheal, and clearing away heat and discharging pus, for edema, beriberi, dysuria, arthralgia chiefly caused by damp pathogen is arrested love, and insufficiency of the spleen generation is rushed down, lung abscess intestinal infections, verruca plana.
The main chemical compositions of Radix Codonopsis comprises that triterpenes and thing are without bringing up terpene, tangshenoside, codopiloic acid, Radix Codonopsis lactone, Rhizoma Atractylodis lactone, alnulin, acetic acid fat, syringoside, polysaccharide; can improve ability of learning and memory; natural activity is had to inhibitory action; acute ischemia due to hypophysis is had to certain protective role; can increase erythrocyte and hemoglobin, remove microcirculation disturbance, antiulcer; mucosal lesion, strengthens and exempts from service and oxygen lack resistant function.Its function comprises: invigorating the spleen and replenishing QI, and invigorating the spleen and benefiting QI, deficiency of the spleen and lung, the cardiopalmus of breathing hard, anorexia and loose stool, dyspnea due to deficiency cough, interior-heat is quenched one's thirst.
The main chemical compositions of the Radix Aucklandiae is Radix Aucklandiae lactone, has convulsion love effect due to pair anti-acetylcholine and histamine, and small intestinal is had to slight excitation, reduce small intestinal tonicity and rhythmicity, reduce blood pressure, blood vessel dilating, suppress heart, suppress the effect of streptococcus, golden yellow and Staphylococcus albus, fungus.Its function comprises: promoting the circulation of QI to relieve pain, and strengthening the spleen to promote digestion, breast gastral cavity distending pain, heavy after dysentery, food stagnation does not disappear, anorexia.
The main chemical compositions of Rhizoma Chuanxiong comprises volatile oil, ferulic acid, Rhizoma Ligustici lactone, Rhizoma Chuanxiong phenol, can increase coronary artery blood flow, reduce coronary resistance, promote tremulous pulse microcirculation, platelet aggregation is had to depolymerisation, improve myocardial oxygen delivery, significantly lasting hypotensive effect, improve whole blood viscosity and red cell deformability, suppress biosynthesis and the activity of thromboxane A2.It can be used for amenorrhea dysmenorrhea, lump in the abdomen stomachache, the twinge of the breast side of body, tumbling and swelling, headache, rheumatic arthralgia.
The main chemical compositions of Radix Saposhnikoviae comprises methyl visamminol glycosides, Radix Angelicae Sinensis acyl hamaudol, cimifugin, peucedanin, to staphylococcus aureus, and beta hemolytic streptococcus, streptococcus pneumoniae, fungus has inhibitory action, has antiallergic, suppresses trachea, ileum smooth muscle anaphylaxis is shunk, strengthen the phagocytic function of peritoneal macrophage, antipyretic, analgesia, calmness, antiinflammatory action.Its function comprises: the but wind that induces sweat, and victory is wet, relieving convulsion, headache due to common cold, rheumatic arthralgia, extremity are arrested love, rubella pruritus, tetanus
The main chemical compositions of Radix Cynanchi Paniculati comprises C21 steroid, cynapanoside, Bai wei glycosides, have analgesic activity, sedation, can reduce coronary artery blood flow, improve myocardial metabolism, alleviate myocardial ischemia, has effect for reducing blood fat, and prevention of arterial is atherosis, to staphylococcus aureus, escherichia coli, bacterium sonnei, bacillus pyocyaneus has inhibitory action.Its function comprises: sedation-analgesia, wet removing toxic substances, rheumatic arthralgia, headache, toothache, traumatic injury, dizziness, skin eczema, snake bite and insect sting.
The main chemical compositions of the Cortex Eucommiae comprises multiple lignanoid, Phenylpropanoid Glycosides and iridoid, there is hypotensive activity, reuse and can produce toleration, can excited pituitary adrenal system function, improve the phagocytic function of peritoneal macrophage, can resist the immunosuppressive action of hydrocortisone.Its function comprises: invigorating the liver and kidney, and bone and muscle strengthening, antiabortive, lumbago due to renal deficiency, muscles and bones is unable, and leak blood pregnant morning, frequent fetal movement, hypertension.
The main chemical compositions of bar halberd comprises the blue glycosides of crystal, tetrem acyl asperuloside, emodin, methyl ether, the different Radix Rubiae element of methyl, there is the effect of the adrenocortical hormone of promotion sample, growth to myeloid cell has facilitation, increase the quantity of leukocyte, the movement time of energy prolongation activity, has defying age, reduce cholesterol, the effect for the treatment of and prevention of arterial blood vessel scleratheroma.Its function comprises: kidney-replenishing, and bone and muscle strengthening, but rheumatism, impotence and seminal emission, cold womb is infertile, menoxenia, few abdomen cold type of pain, rheumatic arthralgia, muscles and bones flaccidity is soft.
The main chemical compositions of Fructus Psoraleae comprises psoralen, Coryfolin, second element, energy coronary artery dilator, has higher selectivity, can strengthen myocardium contractility, antibacterial, anthelmintic action, can treat vitiligo, Niu Pi Xian, can topical application and for oral administration, body intestinal tube is had to excitation, there is to relaxation effect in uterus, also have estrogen action.Its function comprises: warming the kidney to activate YANG, and improving inspiration by invigorating kidney-QI, antidiarrheal, impotence and seminal emission enuresis frequent micturition, waist paint cold type of pain, suffers from a deficiency of the kidney and breathes heavily, and generation is rushed down just before dawn, externally treating leucoderma, alopecia areata.
Flos Carthami main chemical compositions comprises saffloside, the awake glycosides of Flos Carthami, Flos Carthami polysaccharide, Palmic acid, cinnamic acid, there is vasodilative effect, can reduce coronary resistance, increase coronary artery blood flow, improve Nutritional myocardium blood flow amount, have anti-blood and the anti-thrombosis function of doubting, can excited uterus, low dose makes uterus that rhythmicity contraction occur, and heavy dose makes the love of uterus muscle convulsion, can reduce the blood lipid level such as cholesterol in serum and triglyceride.Its function comprises: promoting blood circulation to remove obstruction in the collateral, and eliminating stasis to stop pain, for amenorrhea, dysmenorrhea, lochia, WEIJIA mass in the abdomen, injury from falling down, skin ulcer pain swells and ache.
The main chemical compositions of Radix Angelicae Sinensis comprises Rhizoma Ligustici lactone, n-butene acid lactone, ferulic acid, umbelliferone, sickleleaf jin alcohol, the many-sided functional activity that regulates uterine smooth muscle of energy, excited or inhibition uterus, can increase myocardial blood supply, reduce myocardial oxygen consumption, reduce vascular resistance, increase circulation volume, arrhythmia, expansion peripheral blood vessel, reduce blood pressure, have anti-pernicious anemia effect, can anticoagulant.Its function comprises: enrich blood and invigorate blood circulation, menstruction regulating and pain relieving, loosening bowel to relieve constipation, blood deficiency dull yellowish colored skin, dizzy cardiopalmus, menoxenia, amenorrhea dysmenorrhoea, asthenia cold abdominalgia, dryness of the intestine constipation, rheumatic arthralgia, injury from falling down, ulcer sores.
The main chemical compositions of Rhizoma Curculiginis comprises aobvious curculigoside, Rhizoma Curculiginis element, orcin glucoside, lycorine, Yuccagenin, there is the effect of the former state of adaptation, can extend the length of one's sleep that penta bar is induced than holder, extend Picrotoxin eclamptogenic incubation period, the erythrocytic propagation of bone sample is had to facilitation, there is the immunity of enhancing, defying age, delay reproductive system aging, antiinflammatory, coronary artery dilator, heart tonifying, accelerate heart rate, promote gallbladder contraction effect, energy kidney-replenishing, bone and muscle strengthening, but cold-damp, can be used for sexual impotence cold sperm, muscles and bones flaccidity is soft, the cold numbness of waist paint, yang deficiency cold diarrhea.
The main chemical compositions of Herba Epimedii comprises icariin, icariresinol, total flavones, can make erythrocyte immune serum hemolysis levels height, promote spleen antibody-producting cell to increase, and can improve lymhocyte transformation rate, strengthen immunologic function, Peritoneal Macrophage Phagocytosis is strengthened, epimedium brevicornum polysaccharide can Xian the myelocyte rate of increase and the Synthesis of DNA rate of " sexual impotence " due to work Ti Gao Yang base urea, have heart tonifying, resist myocardial ischemia, increase coronary artery blood flow, antiinflammatory, effect such as antibacterial grade.Kidney-replenishing, bone and muscle strengthening, but rheumatism, can be used for impotence and seminal emission, and muscles and bones flaccidity is soft, rheumatic arthralgia, numb love, the climacteric hypertension of arresting.
Acupuncture and moxibustion treatment is the one tradition treatment method in China's traditional Chinese medical science naturopathy, and acupuncture and moxibustion treatment is divided into two parts: moxibustion therapy and pin therapy, their curative principle is different.Moxibustion, i.e. thermotherapy, it is for not enough causing in human body that blood, body fluid operate the pain that the local body pathological changes of not normal generation causes, help blood of human body, body fluid circulation recovery normally to reach the effect of curing the disease by external heat.Moxibustion therapy is a kind of traditional method of China's Chinese traditional treatment rheumatic ostalgia, and it has following advantage: 1) energy blood circulation promoting speedup, makes blood capillary more unobstructed; 2) can help pore to open and close, make the inside and outside liquid of skin, aspiration arrange freely, in holder with the balance of ambient pressure, 3) the interior energy of enhancing human body, contribute to obesity that physical stamina letdown is caused, rheumatoid treatment.
Prolapse of lumbar intervertebral disc is that the fibrous ring mantle in the middle of vertebral body is excessive and unexpected in external force or spontaneous internal force, cause the vertebra core of the excessive generation of vertebra core maltha in vertebral body outstanding and cause fibrous ring mantle to tear, oppress adjacent soft tissue, blood vessel, neural and produce and ache and fiber crops pain, when particularly sciatic nerve and nervus centralis are pressed, produce strong file pain.To be the single joint of vertebral body refute and connect the cartilage of position and the evagination hypertrophy of soft tissue lesions generation with being connected fibrous ring lumbar vertebra hyperosteogeny, and the generation reason relative complex of this disease substantially can be advised and be received as 1) the traumatic formation hyperosteogeny of luring; 2) habitual compressing forms hyperosteogeny; 3) body constitution degeneration osteoporosis forms hyperosteogeny.To be that cartilaginous opereulum is outstanding cause oppressing adjacent soft tissue, blood vessel, neural aching and fiber crops pain of producing, its oppress sciatic nerve and nervus centralis the same as prolapse of lumbar intervertebral disc to lumbar vertebra hyperosteogeny.Upper two kinds of disease reveal any symptomses are basic identical, and it is diverse that pathotype becomes, and they are to belong to different levels, different series from structure.Naturopathy can only play alleviation to it can not play radical cure effect, prolapse of lumbar intervertebral disc to early origin and slight lumbar vertebra hyperosteogeny, when changing, heat energy in body produces internal gas pressure or outside climate variation generation external pressure increase blood vessel, fibrous tissue Guan Peng rises and causes the sick position extruding of spine adjacent nerve, blood vessel, the pain that spongy tissue produces, can relax to lead to by physical therapy and solve, but in the time that vertebra core is given prominence to the real pressuring nerve in bone regeneration place, when inner and outer air pressure does not change all feels pain, naturopathy can't resolve.Surgical operation is the effective naturopathy solving modern age, to excision outstanding and preneoplastic lesions portion, can remove the pain of nervous system compressing, but operation risk brings wound again to person's trouble, can not change pathological changes root, after most of operation in patients, has recurrence.
The traditional Chinese medical science is by the material composition in medicine or food, regulate and control the each organ of human body and organize required material, utilize the chemical trace element in material to pass through Endophytic bacteria group's decomposition chemical combination, produce the material composition of various favourable human normals growths, draw or disappear and exceed standard or the material composition that lacks reaches and cures the disease to each tissue growth process.The traditional Chinese medical science thinks that human body has the ability of self-inhibition and generation and reparation, required various nutritional labelings in body, secretions, blood, maintains the metabolism of human normal life, the all living things of the each body of composition human body is required, can be undertaken from making by the each organ of human body, the generation to disease and the intrusion of exterior materials, human body has the immunologic mechanism of self-rehabilitation, the traditional Chinese medical science cures the disease to recover the visceral-qi coordination of the each organ of organ function balance, reaches the object of radical curing of disease.The theory of Chinese medicine is that theoretical direction has been established in the development of Chinese medicine, my late grandfather's accumulation of 5000 years makes Chinese medicine form function, drug effect, the property of medicine, formula, processing, concoct, medicaments etc. are Scientific Usage of Drugs treatment method disaggregatedly, though there is no the analysis and guidance of modern science, China sage of the past can utilize the chemical composition in the natural materials such as animal, plant, mineral to solve disease.
Treatment prolapse of lumbar intervertebral disc is mainly to solve the problem that vertebra Anular disruption is repaired and colloid vertebra core evagination bounces back, we know that the rehabilitation of human body needs the inhibition and generation of self human body to recover, utilize human body self characteristic we adopt Radix Codonopsis, Semen Coicis to help growth and the propagation of the soft tissues such as health erythrocyte, protein, fibrous membrane, promote self repairing of spinal column damaged fibers film, the fibrous ring fascia breaking is recovered to normal, utilize bar halberd, Fructus Psoraleae, the Cortex Eucommiae to help the colloid vertebra core retraction in spine, to reach the object of curing prolapse of lumbar intervertebral disc, lumbar vertebra hyperosteogeny is mainly wound, impairment caused by overstrain, habitual damage, the bone structure pathological changes producing, utilize Flos Carthami to solve bone pathological changes, utilize Radix Angelicae Sinensis, Rhizoma Typhonii can help the rehabilitation of sclerotin, can be by manufacturing erythrocyte, supplement the calcification that flesh and blood deficiency causes, Flos Carthami can be eliminated the pathological changes that sclerotin injury stays, the delivery that Rhizoma Typhonii helps improve calcium loss and blood flow reaches cures the disease, utilize Rhizoma Curculiginis to have facilitation to the erythrocytic propagation of bone sample, there is the immunity of enhancing, defying age, delay system aging, antiinflammatory, coronary artery dilator, the effect of bone and muscle strengthening, can eliminate hyperosteogeny and the waist and knee numbness of the soft and relaxed and comfortable generation of skeletal framework of muscles and bones flaccidity, Herba Epimedii can make erythrocyte immune serum hemolysis levels height, promotes spleen antibody-producting cell to increase, and improves lymhocyte transformation rate, strengthens immunologic function, can significantly improve the self-rehabilitation of proliferation of bone marrow cells rate and Synthesis of DNA rate help skeleton, prolapse of lumbar intervertebral disc and lumbar vertebra hyperosteogeny in pathological process all tangible become the feature of rheumatism, cause that local organization aches, in order to treat rheumatism and rehabilitation human body, eliminate pain simultaneously, adopt Radix Cynanchi Paniculati, Radix Saposhnikoviae, Rhizoma Chuanxiong, the Radix Aucklandiae, Rhizoma Zingiberis can help circulation of qi promoting, promote blood circulation, dry, the effect of pain relieving, every kind of Chinese medicine all comprises different chemical compositions, the different pharmaceutical component of Chinese medicine, manufacture method, number change, using method, can change the efficiency of medicine and the essence of curing the disease.
Skin pore is easily opened a business the in the situation that of heating, medicine also can absorb by pore fast, in human body, some waste gas and waste liquid also can be arranged outward simultaneously, human body inner and outer air pressure reaches balance, in human body, body fluid and blood lines are unobstructed, medicine is sent to disease position fast by blood vessel access, helps outstanding and the rehabilitation of hypertrophy place.Because Chinese medicine of the present invention does not need to transport by digestive system and internal organs official rank passage, therefore efficiently solve medicine the thorn of internal organs is hit to damage.When human body is accepted external heat, the cold-damp gas that human body produces because physical ability is not enough can be eliminated along with sanguimotor speeding rapidly.Although help medicine to absorb fast by heating energy, when but human body is heated, blood circulation can speed, blood circulation change is disadvantageous to human body natural's growth for a long time, and medicine is from external absorption, in the time that medicine removes from human body, the property of medicine also disappears simultaneously, therefore for solve medicine quick absorption we medicine is dissolved and in wine, makes medicinal liquid, liquid medicine is easier to pore and sucks human body, in the time that complying with in body, medicinal liquid prevents baking the burning to epidermis of outer heater simultaneously, the suction volume of wine also needs to control, according to division of day and night blood running one circle of the theoretical human body of traditional Chinese medical science blood circulation, therefore medicine liquid heating physical therapy is decided to be to two hours service time, allow medicine fully be transported to the each deep layer of health position.Medicine moxibustion physical therapy in two hours completes and pastes externally applied ointment again, and externally applied plaster generally adopts attaching in 24 hours, makes focus can obtain for a long time the rehabilitation of medicine, and externally applied plaster only acts on fixed position, therefore can not injure other position of human body.External treatment plaster attaches the vacuum producing with skin, can force waste gas liquid in medicine importing suction body.
The hot moxibustion of our invention and external therapy of Chinese herb and the occupation mode of forcing on, possess and have several advantages: 1) therapeutic effect is fast; 2) treat easy to use; 3) safety during treatment; 4) sufferer exempt take medicine arduous; 5) while avoiding treating and the repelling each other of other medicines.Adopt this medicine and corresponding using method, treatment prolapse of lumbar intervertebral disc and hyperosteogeny, healing time shortens half than orally taken for curing, when seizure of disease, adopt the method can play the effect immediately taking effect, for prolapse of lumbar intervertebral disc need perform an operation excision person suffer from, use three to five days state of an illness of this therapy greatly to slow down, use ten days, patient's pain disappears substantially, uses 20 days patient's nerves to draw pain situation to eliminate, and uses the basic rehabilitation of patient in 30 days to cure.Adopting the present invention to go through 5 years is the patient treatments such as 2,000 multidigit waists, neck, rheumatism, osteodynia, and cure rate reaches more than 95%, evident in efficacy being worthy to be popularized.
Detailed description of the invention
Below in conjunction with specific embodiment, the present invention is further described.
Embodiment 1:
A kind of Chinese medicine and using method for the treatment of prolapse of lumbar intervertebral disc and hyperosteogeny
Prepare Chinese medicine:
1, prepare raw material: 8 grams of Rhizoma Zingiberiss, 6 grams of Rhizoma Typhoniis, 15 grams of Semen Coiciss, 10 grams of Radix Codonopsis, 6 grams of the Radix Aucklandiae, 8 grams of Rhizoma Chuanxiong, 8 grams of Radix Saposhnikoviaes, 8 grams of Radix Cynanchi Paniculatis, 10 grams of the Cortexs Eucommiae, 8 grams of halberds of bar, 10 grams of Fructus Psoraleaes, 8 grams, Flos Carthami, 10 grams of Radix Angelicae Sinensis, 10 grams of Rhizoma Curculiginises, 10 grams of Herba Epimedii.
2, above-mentioned raw materials added 1200 grams of part soaking in Chinese liquor after 15 days.
Prepare plaster:
1, prepare fine drug powder material: 8 grams of Rhizoma Zingiberiss, 6 grams of Rhizoma Typhoniis, 15 grams of Semen Coiciss, 10 grams of Radix Codonopsis, 6 grams of the Radix Aucklandiae, 8 grams of Rhizoma Chuanxiong, 8 grams of Radix Saposhnikoviaes, 8 grams of Radix Cynanchi Paniculatis, 10 grams of the Cortexs Eucommiae, 8 grams of halberds of bar, 10 grams of Fructus Psoraleaes, 8 grams, Flos Carthami, 10 grams of Radix Angelicae Sinensis, 10 grams of Rhizoma Curculiginises, 10 grams of Herba Epimedii, by this material pulverizing, sieve, make nano-grade medicine fine materials stand-by.
2, prepare plaster substrate: prepare raw material: 100 grams of Vegetable oil lipoproteines, 400 grams of Colophonium, 400 grams of arabic gums, 100 grams of Cera Flavas, 30 grams of azones, with pot heating, gradation is added and boiled, by the substrate spreading for cooling boiling, place that within 3 months, to move back malicious ageing for subsequent use.
3, prepare plaster: substrate heating good ageing is dissolved and fine powder drug material is added in the gum base dissolving and makes plaster.
Using method:
This herb liquid of preparing is applied to focus outward, thermotherapy 2 hours, human body heating temperature is no more than 45 degree, then in affected area externally applied plaster 24 hours.
Embodiment 2:
A kind of Chinese medicine and using method for the treatment of prolapse of lumbar intervertebral disc and hyperosteogeny
Prepare Chinese medicine:
1, prepare raw material: 40 grams of Rhizoma Zingiberiss, 30 grams of Rhizoma Typhoniis, 75 grams of Semen Coiciss, 50 grams of Radix Codonopsis, 30 grams of the Radix Aucklandiae, 40 grams of Rhizoma Chuanxiong, 40 grams of Radix Saposhnikoviaes, 40 grams of Radix Cynanchi Paniculatis, 50 grams of the Cortexs Eucommiae, 40 grams of halberds of bar, 50 grams of Fructus Psoraleaes, 40 grams, Flos Carthami, 50 grams of Radix Angelicae Sinensis, 50 grams of Rhizoma Curculiginises, 50 grams of Herba Epimedii.
2, above-mentioned raw materials added 6000 grams of part soaking in Chinese liquor after 10 days.
Prepare plaster:
1, prepare fine drug powder material: 80 grams of Rhizoma Zingiberiss, 60 grams of Rhizoma Typhoniis, 150 grams of Semen Coiciss, 100 grams of Radix Codonopsis, 60 grams of the Radix Aucklandiae, 80 grams of Rhizoma Chuanxiong, 80 grams of Radix Saposhnikoviaes, 80 grams of Radix Cynanchi Paniculatis, 100 grams of the Cortexs Eucommiae, 80 grams of halberds of bar, 100 grams of Fructus Psoraleaes, 80 grams, Flos Carthami, 100 grams of Radix Angelicae Sinensis, 100 grams of Rhizoma Curculiginises, 100 grams of Herba Epimedii, by this material pulverizing, sieve, make nano-grade medicine fine materials stand-by.
2, prepare plaster substrate: prepare raw material: 200 grams of Vegetable oil lipoproteines, 800 grams of Colophonium, 800 grams of arabic gums, 200 grams of Cera Flavas, 60 grams of azones, with pot heating, gradation is added and boiled, by the substrate spreading for cooling boiling, place that within 3 months, to move back malicious ageing for subsequent use.
3, prepare plaster: substrate heating good ageing is dissolved and fine powder drug material is added in the gum base dissolving and makes plaster.
Using method:
This Chinese medicine of preparing is applied to focus outward, thermotherapy 1 hour, human body heating temperature is no more than 45 degree, then in affected area externally applied plaster 4 hours.
Embodiment 3:
A kind of Chinese medicine and using method for the treatment of prolapse of lumbar intervertebral disc and hyperosteogeny
Prepare Chinese medicine:
1, prepare raw material: 32 grams of Rhizoma Zingiberiss, 24 grams of Rhizoma Typhoniis, 60 grams of Semen Coiciss, 40 grams of Radix Codonopsis, 24 grams of the Radix Aucklandiae, 32 grams of Rhizoma Chuanxiong, 32 grams of Radix Saposhnikoviaes, 32 grams of Radix Cynanchi Paniculatis, 40 grams of the Cortexs Eucommiae, 32 grams of halberds of bar, 40 grams of Fructus Psoraleaes, 32 grams, Flos Carthami, 40 grams of Radix Angelicae Sinensis, 40 grams of Rhizoma Curculiginises, 40 grams of Herba Epimedii.
2, above-mentioned raw materials added 4800 grams of part soaking in Chinese liquor after 20 days.
Prepare plaster:
1, prepare fine drug powder material: 32 grams of Rhizoma Zingiberiss, 24 grams of Rhizoma Typhoniis, 60 grams of Semen Coiciss, 40 grams of Radix Codonopsis, 24 grams of the Radix Aucklandiae, 32 grams of Rhizoma Chuanxiong, 32 grams of Radix Saposhnikoviaes, 32 grams of Radix Cynanchi Paniculatis, 40 grams of the Cortexs Eucommiae, 32 grams of halberds of bar, 40 grams of Fructus Psoraleaes, 32 grams, Flos Carthami, 40 grams of Radix Angelicae Sinensis, 40 grams of Rhizoma Curculiginises, 40 grams of Herba Epimedii, by this material pulverizing, sieve, make nano-grade medicine fine materials stand-by.
2, prepare plaster substrate: prepare raw material: 500 grams of Vegetable oil lipoproteines, 2000 grams of Colophonium, 2000 grams of arabic gums, 500 grams of Cera Flavas, 150 grams of azones, with pot heating, gradation is added and boiled, by the substrate spreading for cooling boiling, place that within 3 months, to move back malicious ageing for subsequent use.
3, prepare plaster: substrate heating good ageing is dissolved and fine powder drug material is added in the gum base dissolving and makes plaster.
Using method:
This Chinese medicine of preparing is applied to focus outward, thermotherapy 3 hours, human body heating temperature is no more than 45 degree, then in affected area externally applied plaster 10 hours.
Embodiment 4:
A kind of Chinese medicine and using method for the treatment of prolapse of lumbar intervertebral disc and hyperosteogeny
Prepare Chinese medicine:
1, prepare raw material: 48 grams of Rhizoma Zingiberiss, 36 grams of Rhizoma Typhoniis, 90 grams of Semen Coiciss, 60 grams of Radix Codonopsis, 36 grams of the Radix Aucklandiae, 48 grams of Rhizoma Chuanxiong, 48 grams of Radix Saposhnikoviaes, 48 grams of Radix Cynanchi Paniculatis, 60 grams of the Cortexs Eucommiae, 48 grams of halberds of bar, 60 grams of Fructus Psoraleaes, 48 grams, Flos Carthami, 60 grams of Radix Angelicae Sinensis, 60 grams of Rhizoma Curculiginises, 60 grams of Herba Epimedii.
2, above-mentioned raw materials added 7200 grams of part soaking in Chinese liquor after 10 days.
Prepare plaster:
1, prepare fine drug powder material: 64 grams of Rhizoma Zingiberiss, 48 grams of Rhizoma Typhoniis, 120 grams of Semen Coiciss, 80 grams of Radix Codonopsis, 48 grams of the Radix Aucklandiae, 64 grams of Rhizoma Chuanxiong, 64 grams of Radix Saposhnikoviaes, 64 grams of Radix Cynanchi Paniculatis, 80 grams of the Cortexs Eucommiae, 64 grams of halberds of bar, 80 grams of Fructus Psoraleaes, 64 grams, Flos Carthami, 80 grams of Radix Angelicae Sinensis, 80 grams of Rhizoma Curculiginises, 80 grams of Herba Epimedii, by this material pulverizing, sieve, make nano-grade medicine fine materials stand-by.
2, prepare plaster substrate: prepare raw material: 500 grams of Vegetable oil lipoproteines, 1000 grams of Colophonium, 1000 grams of arabic gums, 500 grams of Cera Flavas, 20 grams of azones, with pot heating, gradation is added and boiled, by the substrate spreading for cooling boiling, place that within 3 months, to move back malicious ageing for subsequent use.
3, prepare plaster: substrate heating good ageing is dissolved and fine powder drug material is added in the gum base dissolving and makes plaster.
Using method:
This Chinese medicine of preparing is applied to focus outward, thermotherapy 3.5 hours, human body heating temperature is no more than 45 degree, then in affected area externally applied plaster 20 hours.
The above; it is only preferably specific embodiment of the present invention; but protection scope of the present invention is not limited to this; any be familiar with those skilled in the art the present invention disclose technical scope in; be equal to replacement or changed according to technical scheme of the present invention and design thereof, all should be encompassed in protection scope of the present invention.
Claims (5)
1. treat the medicine of prolapse of lumbar intervertebral disc and hyperosteogeny for one kind, it is characterized in that, formed by Chinese medicine and plaster, described Chinese medicine is made up of the raw material of following weight portion: 8 parts of Rhizoma Zingiberiss, 6 parts of Rhizoma Typhoniis, 15 parts of Semen Coiciss, 10 parts of Radix Codonopsis, 6 parts of the Radix Aucklandiae, 8 parts of Rhizoma Chuanxiong, 8 parts of Radix Saposhnikoviaes, 8 parts of Radix Cynanchi Paniculatis, 10 parts of the Cortexs Eucommiae, 8 parts of halberds of bar, 10 parts of Fructus Psoraleaes, 8 parts, Flos Carthami, 10 parts of Radix Angelicae Sinensis, 10 parts of Rhizoma Curculiginises, 10 parts of Herba Epimedii, and above-mentioned raw materials added 1200 parts of soaking in Chinese liquor after 15 days; Described plaster is made up of following raw material: 8 parts of Rhizoma Zingiberiss, 6 parts of Rhizoma Typhoniis, 15 parts of Semen Coiciss, 10 parts of Radix Codonopsis, 6 parts of the Radix Aucklandiae, 8 parts of Rhizoma Chuanxiong, 8 parts of Radix Saposhnikoviaes, 8 parts of Radix Cynanchi Paniculatis, 10 parts of the Cortexs Eucommiae, 8 parts of halberds of bar, 10 parts of Fructus Psoraleaes, 8 parts, Flos Carthami, 10 parts of Radix Angelicae Sinensis, 10 parts of Rhizoma Curculiginises, 10 parts of Herba Epimedii.
2. a method of preparing medicine as claimed in claim 1, is characterized in that, the manufacture method of described plaster comprises: make nanoscale fine powder drug material by described material pulverizing, after sieving, plaster substrate and fine powder drug material are formulated as to plaster.
3. the preparation method of a medicine as claimed in claim 2, it is characterized in that, described plaster substrate is made up of Vegetable oil lipoprotein, Colophonium, arabic gum, Cera Flava, azone raw material, heat each raw material, boil, spreading for cooling, places that within 3 months, to move back malicious ageing for subsequent use, and the substrate after ageing is heated and dissolves and fine powder drug material is added in the gum base dissolving and makes plaster.
4. a preparation method for medicine as claimed in claim 3, is characterized in that, the weight ratio of described plaster substrate raw material is: Vegetable oil lipoprotein: Colophonium: arabic gum: Cera Flava: azone is 1:4:4:1:0.3.
5. a preparation method for medicine as claimed in claim 4, is characterized in that,
(1) prepare Chinese medicine:
1. prepare raw material: 8 grams of Rhizoma Zingiberiss, 6 grams of Rhizoma Typhoniis, 15 grams of Semen Coiciss, 10 grams of Radix Codonopsis, 6 grams of the Radix Aucklandiae, 8 grams of Rhizoma Chuanxiong, 8 grams of Radix Saposhnikoviaes, 8 grams of Radix Cynanchi Paniculatis, 10 grams of the Cortexs Eucommiae, 8 grams of halberds of bar, 10 grams of Fructus Psoraleaes, 8 grams, Flos Carthami, 10 grams of Radix Angelicae Sinensis, 10 grams of Rhizoma Curculiginises, 10 grams of Herba Epimedii;
2. above-mentioned raw materials added 1200 grams of soaking in Chinese liquor after 15 days;
(2) prepare plaster:
1. prepare fine drug powder material: 8 grams of Rhizoma Zingiberiss, 6 grams of Rhizoma Typhoniis, 15 grams of Semen Coiciss, 10 grams of Radix Codonopsis, 6 grams of the Radix Aucklandiae, 8 grams of Rhizoma Chuanxiong, 8 grams of Radix Saposhnikoviaes, 8 grams of Radix Cynanchi Paniculatis, 10 grams of the Cortexs Eucommiae, 8 grams of halberds of bar, 10 grams of Fructus Psoraleaes, 8 grams, Flos Carthami, 10 grams of Radix Angelicae Sinensis, 10 grams of Rhizoma Curculiginises, 10 grams of Herba Epimedii, by this material pulverizing, sieve, make nano-grade medicine fine materials stand-by;
2. prepare plaster substrate: prepare raw material: 100 grams of Vegetable oil lipoproteines, 400 grams of Colophonium, 400 grams of arabic gums, 100 grams of Cera Flavas, 30 grams of azones, with pot heating, gradation is added and boiled, by the substrate spreading for cooling boiling, place that within 3 months, to move back malicious ageing for subsequent use;
3. prepare plaster: substrate heating good ageing is dissolved and fine powder drug material is added in the gum base dissolving and makes plaster.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310008908.2A CN103055295B (en) | 2013-01-10 | 2013-01-10 | Chinese medicine for treating lumbar disc herniation and hyperosteogeny and use method of Chinese medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310008908.2A CN103055295B (en) | 2013-01-10 | 2013-01-10 | Chinese medicine for treating lumbar disc herniation and hyperosteogeny and use method of Chinese medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103055295A CN103055295A (en) | 2013-04-24 |
| CN103055295B true CN103055295B (en) | 2014-12-10 |
Family
ID=48098388
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310008908.2A Expired - Fee Related CN103055295B (en) | 2013-01-10 | 2013-01-10 | Chinese medicine for treating lumbar disc herniation and hyperosteogeny and use method of Chinese medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103055295B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101551891B1 (en) * | 2013-09-12 | 2015-09-09 | 삼천당제약주식회사 | Topical composition comprising the combined extract of Acanthopanax koreanum Nakai and Crinum asiaticum var. japonicum stimulating hair growth and preventing hair loss |
| CN105213260A (en) * | 2015-10-27 | 2016-01-06 | 桂林瑞丰环保微生物应用研究所 | Low stimulation nial polish of a kind of environmental protection and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101041036A (en) * | 2006-03-24 | 2007-09-26 | 张臣 | Medicine liquid for reducing pain for external application |
| CN101337059A (en) * | 2007-07-06 | 2009-01-07 | 贾清学 | Plaster for treating hyperosteogeny and preparation method thereof |
| CN101874892A (en) * | 2009-04-30 | 2010-11-03 | 乐武平 | Health-care external liquid medicine for treating bone hyperplasia and lumbar disc hernia |
| CN101987122A (en) * | 2009-08-05 | 2011-03-23 | 吉林一正药业集团有限公司 | Medicament for easing pain of human body and preparation method thereof |
| CN102441152A (en) * | 2010-10-10 | 2012-05-09 | 潘立芝 | Chinese medicinal liquor for treating rheumatic disease |
-
2013
- 2013-01-10 CN CN201310008908.2A patent/CN103055295B/en not_active Expired - Fee Related
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101041036A (en) * | 2006-03-24 | 2007-09-26 | 张臣 | Medicine liquid for reducing pain for external application |
| CN101337059A (en) * | 2007-07-06 | 2009-01-07 | 贾清学 | Plaster for treating hyperosteogeny and preparation method thereof |
| CN101874892A (en) * | 2009-04-30 | 2010-11-03 | 乐武平 | Health-care external liquid medicine for treating bone hyperplasia and lumbar disc hernia |
| CN101987122A (en) * | 2009-08-05 | 2011-03-23 | 吉林一正药业集团有限公司 | Medicament for easing pain of human body and preparation method thereof |
| CN102441152A (en) * | 2010-10-10 | 2012-05-09 | 潘立芝 | Chinese medicinal liquor for treating rheumatic disease |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103055295A (en) | 2013-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104147577B (en) | A kind of plaster for promoting growth of spur to treat fracture | |
| CN102091203A (en) | External traditional Chinese medicine preparation for treating chronic wounds and preparation method thereof | |
| CN103705751B (en) | Chinese medicine composition being used for the treatment of lumbago due to pathogenic wind-dampness and preparation method thereof | |
| CN104666698A (en) | External-use traditional Chinese medicine ointment for treating gonarthromeningitis and preparation method of traditional Chinese medicine ointment | |
| CN103536858B (en) | Medicine for treating rheumatoid arthritis | |
| CN102772712B (en) | Traditional Chinese medicine composition for treating heat-toxicity, flourishing and blood stasis type diabetic foot | |
| CN104096141A (en) | Traditional Chinese medical composition for treating allergic conjunctivitis | |
| CN103055295B (en) | Chinese medicine for treating lumbar disc herniation and hyperosteogeny and use method of Chinese medicine | |
| CN104306880A (en) | Formula of traditional Chinese medicine for treating cerebral thrombosis | |
| CN104547574A (en) | Traditional Chinese medicine for treating kidney deficiency | |
| CN103860773A (en) | Traditional Chinese medicine composition for treating myocardial ischemia and preparation method thereof | |
| CN103263548A (en) | Embrocation for treating haemorrhoids and application thereof | |
| CN103212001B (en) | Chinese medicinal composition treating diarrhoea | |
| CN104338052A (en) | Formula of traditional Chinese medicine for treating cerebral thrombosis | |
| CN104306741A (en) | A traditional Chinese medicine formula for treating cerebral hemorrhage | |
| CN104013810A (en) | Traditional Chinese medicine (TCM) composition for treating varicocele | |
| CN104189672A (en) | Ointment for treating fasciitis | |
| CN104013950A (en) | Traditional Chinese medicine composition for treating toxin and decay type bedsore and preparation method of composition | |
| CN103690799A (en) | Traditional Chinese medicinal preparation for treating cerebral infarction | |
| CN105362944A (en) | Traditional Chinese medicine ointment for treating orthopedics sprain and contusion | |
| CN104162048A (en) | Traditional Chinese medicine patch for treating knee joint hyperplasia | |
| CN104740193A (en) | Traditional Chinese medicine composition for treating neck-shoulder muscle strain syndrome and preparation method of traditional Chinese medicine composition | |
| CN103860953A (en) | Traditional Chinese medicine plaster for treating synovitis | |
| CN104189670A (en) | Ointment for treating motile type lumbar muscle strain | |
| CN104825856A (en) | Traditional Chinese medicinal composition for treating facial paralysis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141210 |